Day: April 25, 2022

Agriculture Equipment Market Worth USD 253.28 Billion by 2028 | Agriculture Equipment Industry Exhibiting CAGR of 7.0% During 2021-2028

Written by Customer Service on April 25, 2022. Posted in Mergers And Acquisitions.

Companies covered in the agriculture equipment market are Deere & Company, AGCO Corporation, Alamo Group Inc., Kubota Corporation, Mahindra & Mahindra Ltd., CNH Industrial N.V., Iseki & Co., Ltd., Claas KGaA mbH, China National Machinery Industry Corporation, Valmont Industries, Inc., Sonalika Group – Sonalika International Tractor, SDF S.p.A., Escort Limited, Agrostroj Pelhrimov A.s., Weifang Euroking Machinery, Concern Tractor Plants, Agromaster. Pune, India , April 25, 2022 (GLOBE NEWSWIRE) — The Global Agriculture Equipment Market size is anticipated to reach USD 253.28 billion by 2028 and exhibit a CAGR of 7.0% during the forecast period. The increasing favorable government initiatives, reduced import duties and interest rates, and the ease of financing are some of the factors expected to bolster the market’s...

Reminder: Program for the publication of Yara International ASA first quarter results 2022

Written by Customer Service on April 25, 2022. Posted in Earnings Releases And Operating Results.

The Yara International ASA first quarter 2022 results will be published on Wednesday 27 April 2022 at 08:00 CEST. An on-line presentation will be held at 12:00 CEST, hosted by Yara President and CEO Svein Tore Holsether. The presentation will be held in English. The report, presentation and webcast will be available at the above mentioned times at:yara.com/investor-relations/latest-quarterly-report/ There will also be a conference call at 13:00 CEST the same day with an opportunity to ask questions to Yara’s management. Please use this link for online registration for the conference call: http://emea.directeventreg.com/registration/4661876Participants must register in advance of the conference using the link provided. Upon registering, you will be provided with participant dial-in numbers, Direct Event passcode and unique registrant...

Dividend Payments Ex-date of Coop Pank AS

Written by Customer Service on April 25, 2022. Posted in Dividend Reports And Estimates.

For the year of 2021 Coop Pank AS will pay dividend in the net amount of 3 eurocents per share. The list of shareholders entitled to receive dividend will be established as at 28.04.2022 COB in the settlement system. Consequently, the day of change of the rights related to the shares (ex-dividend date) is set to 27.04.2022. From this day onwards, the person acquiring the shares will not have the right to receive dividend for the financial year 2021. Dividend shall be disbursed to the shareholders on 03.05.2022. Coop Pank, based on Estonian capital, is one of the five universal banks operating in Estonia. The number of clients using Coop Pank for their daily banking reached 122,400. Coop Pank aims to put the synergy generated by the interaction of retail business and banking to good use and to bring everyday banking services closer to people’s...

Refractories Market Expected to Rise $44.82 Billion by 2029 | Refractories Industry Exhibiting a CAGR of 4.5% during the Forecast Period 2022-2029

Written by Customer Service on April 25, 2022. Posted in Mergers And Acquisitions.

Companies covered in refractories market are Beijing Lier High Temperature Materials Co., Ltd. (China), HarbinsonWalker International (U.S.), Intocast Group (Germany), Alsey Refractories Co. (U.S.), Magnezit Group (Russia), Imerys (France), Posco Chemical (South Korea), RHI Magnesita (Austria), Saint-Gobain (France), Vesuvius (U.K.), Puyang Refractories Group Co., Ltd. (China), Refratechnik (Germany), Ruitai Materials Technology Co., Ltd. (China), Kaefer (Norway), Plibrico Company, LLC (U.S.), Krosaki Harima Corporation (Japan) and others. Pune, India, April 25, 2022 (GLOBE NEWSWIRE) — The global refractories market size reached $32.25 billion in 2021. The market valuation is predicted to rise from $33.01 billion in 2022 to $44.82 billion by 2029, registering a CAGR of 4.5% during 2022-2029. The growth of this market is driven...

Polyethylene Market to Worth USD 130.26 Billion by 2027 | PE Industry Exhibiting a CAGR of 3.4% During the Forecast Period 2020-2027

Written by Customer Service on April 25, 2022. Posted in Mergers And Acquisitions.

Companies covered in polyethylene market are INEOS (UK), China Petroleum & Chemical Corporation (China), SABIC (Saudi Arabia), Ducor Petrochemicals (Netherlands), Reliance Industries Limited (India), Formosa Plastic Group (Taiwan), Braskem (Brazil), Repsol (Spain), Borouge (UAE), Borealis AG (Austria), MOL Group (Hungary), Beaulieu International Group (Belgium), and Other Key Players Pune, India, April 25, 2022 (GLOBE NEWSWIRE) — The global polyethylene market is expected to gain momentum from its increasing usage in a wide range of industries owing to various beneficial properties, such as high durability, easy customization, and resistance to moisture.The report states that the PE market size was USD 107.43 billion in 2019 is projected to reach USD 130.26 billion by 2027, exhibiting a CAGR of 3.4% during the forecast period. Get...

Natural Stone and Marble Market to Reach USD 62.58 Billion by 2027 | Natural Stone and Marble Industry Exhibiting a CAGR of 7.57% During the Forecast Period 2020-2027

Written by Customer Service on April 25, 2022. Posted in Mergers And Acquisitions.

Companies covered in natural stone and marble market are Polycor Inc. (Canada), Dimpomar (Portugal), Antolini Luigi & C. S.p.A. (Italy), Dermitzakis Bros S.A. (Greece), Levantina y Asociados de Minerales, S.A. (Spain), MARGRAF (Italy), RANAMAR (Turkey), Temmer Marble(Turkey), Southland Stone USA, Inc. (The United States), Xishi Stone Group (China), CUPA Group (Spain), Aro Granite Industries Ltd. (India), and others. Pune, India, April 25, 2022 (GLOBE NEWSWIRE) — The global natural stone and marble market size is expected to reach USD 62.58 billion by 2027, exhibiting a CAGR of 7.57% during the forecast period. The increasing demand for natural stones such as White Statuario marble for decorative purposes in luxury buildings, home remodeling, and renovation activities will encourage the healthy growth of the market.This information...

Addex to Present at the B. Riley Securities Neuro & Ophthalmology Virtual Investor Conference

Written by Customer Service on April 25, 2022. Posted in Public Companies.

Geneva, Switzerland, April 25, 2022 – Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer, will present at the B. Riley Securities Neuro & Ophthalmology Virtual Investor Conference taking place April 27 – 28, 2022. In his presentation, scheduled for 08:30 PDT / 11:30 EDT / 16:30 BST / 17:30 CEST on April 27, 2022, Mr Dyer will provide a corporate update and discuss recent developments at Addex. A video of each presentation will be available for viewing on-demand by registered participants. Mr Dyer will be available for virtual one-on-one meetings throughout both conferences. For more information or to schedule a one-on-one meeting with management, please contact your conference...

ObsEva Announces Confirmation of Positive CHMP Opinion for Linzagolix, an Oral GnRH Antagonist, for the Treatment of Uterine Fibroids

Written by Customer Service on April 25, 2022. Posted in Public Companies.

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss ExchangeGENEVA, Switzerland – April 25, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has confirmed its previously adopted positive opinion, recommending approval of linzagolix for the treatment of uterine fibroids (UF). The positive CHMP opinion, which was initially adopted on December 16, 2021, was confirmed at the April 2022 CHMP meeting following further review of the linzagolix marketing authorization application. The European Commission (EC) will now review the CHMP recommendation. If approved by the EC, linzagolix will be the only approved oral GnRH antagonist...

Press release Biocartis Group NV: Biocartis Announces Presentation of Three Idylla™ Studies at 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)

Written by Customer Service on April 25, 2022. Posted in Earnings Releases And Operating Results.

PRESS RELEASE: 25 April 2022, 07:00 CEST Biocartis Announces Presentation of Three Idylla™ Studies at 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) Mechelen, Belgium, 25 April 2022 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces that three Idylla™ study posters, of which two on the SeptiCyte® RAPID (developed in collaboration with Immunexpress) and one on the Idylla™ SARS-CoV-2 Test (CE-IVD) and Idylla™ SARS-CoV-2/Flu/RSV Panel (CE-IVD), were presented at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) between 23 – 26 April in Lisbon, Portugal. Herman Verrelst, Chief Executive Officer of Biocartis, commented: “We are pleased to see three study presentations on Idylla™...

Philips delivers Q1 sales of EUR 3.9 billion, with good demand driving 5% comparable order intake growth

Written by Customer Service on April 25, 2022. Posted in Earnings Releases And Operating Results.

April 25, 2022 First-quarter highlightsGroup sales amounted to EUR 3.9 billion, with a 4% comparable sales decline on the back of 9% comparable sales growth in Q1 2021 Comparable order intake increased 5%, driven by the Diagnosis & Treatment businesses and Hospital Patient Monitoring Income from continuing operations amounted to a loss of EUR 152 million, compared to a loss of EUR 34 million in Q1 2021 Adjusted EBITA of EUR 243 million, or 6.2% of sales, compared to 9.5% of sales in Q1 2021 Operating cash flow was an outflow of EUR 227 million, compared to an inflow of EUR 321 million in Q1 2021 Philips provides update on Philips Respironics field action related to specific CPAP, BiPAP and mechanical ventilatorsFrans van Houten, CEO of Royal Philips:“Our customers confirm the relevance of our strategy and portfolio, as evidenced...

Day: April 25, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice